Jul 15, 2026 for the exclusive distribution of REXIM pharmaceutical grade amino acids (GMP) New exclusive distribution agreement for REXIM®amino acids strengthens Brenntag's role in the Biopharma and API markets Brenntag assumes full responsibility for the market development and distribution across most of Europe since July 1 [...]
This is an abstract of the document. To keep reading, click here and get access to the original version.